Literature DB >> 15242740

The sarcoplasmic reticulum proteins are targets for calpain action in the ischemic-reperfused heart.

Raja B Singh1, Punam K Chohan, Naranjan S Dhalla, Thomas Netticadan.   

Abstract

Ca(2+) overload and free-radical injury are two mutually non-exclusive phenomena suggested to cause myocardial ischemia-reperfusion (IR)-induced contractile dysfunction; however, the mechanisms underlying their effects are not clear. One possible mechanism is the proteolytic modification of proteins by Ca(2+)-dependent proteases, such as calpains, which are activated during Ca(2+) overload that occurs in IR. The sarcoplasmic reticulum (SR) plays a central role in mediating cardiac contractility and therefore any impairment in SR function will induce cardiac contractile dysfunction. We therefore investigated the possibility whether SR proteins were the target for calpain action in IR. Langendorff-perfused rat hearts were subjected to IR in the presence and absence of leupeptin, a calpain inhibitor and the effects of calpain inhibition was examined on cardiac performance, SR function, and its regulation by protein phosphorylation as well as expression of SR Ca(2+)-cycling and -regulatory proteins. Our results show a depression in cardiac contractile function and activation of calpain during IR. Treatment with leupeptin recovered cardiac contractile function and attenuated calpain activity in IR hearts. The cardioprotection observed upon leupeptin treatment was associated with improved SR function and regulation. The recovery in SR function and regulation was consistent with prevention of IR-induced decrease in the expression of key SR Ca(2+)-handling and -regulatory proteins. Our results suggest that a downregulation of SR proteins by calpain may be a mechanism by which Ca(2+) overload causes cardiac contractile dysfunction during IR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15242740     DOI: 10.1016/j.yjmcc.2004.04.009

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  25 in total

1.  In vivo administration of calpeptin attenuates calpain activation and cardiomyocyte loss in pressure-overloaded feline myocardium.

Authors:  Santhosh K Mani; Hirokazu Shiraishi; Sundaravadivel Balasubramanian; Kentaro Yamane; Meenakshi Chellaiah; George Cooper; Naren Banik; Michael R Zile; Dhandapani Kuppuswamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-16       Impact factor: 4.733

Review 2.  Calpain system and its involvement in myocardial ischemia and reperfusion injury.

Authors:  Christiane Neuhof; Heinz Neuhof
Journal:  World J Cardiol       Date:  2014-07-26

3.  Molecular Determinants of Calpain-dependent Cleavage of Junctophilin-2 Protein in Cardiomyocytes.

Authors:  Ang Guo; Duane Hall; Caimei Zhang; Tianqing Peng; Jordan D Miller; William Kutschke; Chad E Grueter; Frances L Johnson; Richard Z Lin; Long-Sheng Song
Journal:  J Biol Chem       Date:  2015-06-10       Impact factor: 5.157

4.  Molecular basis of calpain cleavage and inactivation of the sodium-calcium exchanger 1 in heart failure.

Authors:  Pimthanya Wanichawan; Tandekile Lubelwana Hafver; Kjetil Hodne; Jan Magnus Aronsen; Ida Gjervold Lunde; Bjørn Dalhus; Marianne Lunde; Heidi Kvaløy; William Edward Louch; Theis Tønnessen; Ivar Sjaastad; Ole Mathias Sejersted; Cathrine Rein Carlson
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

5.  Calpain protects the heart from hemodynamic stress.

Authors:  Manabu Taneike; Isamu Mizote; Takashi Morita; Tetsuya Watanabe; Shungo Hikoso; Osamu Yamaguchi; Toshihiro Takeda; Takafumi Oka; Takahito Tamai; Jota Oyabu; Tomokazu Murakawa; Hiroyuki Nakayama; Kazuhiko Nishida; Junji Takeda; Naoki Mochizuki; Issei Komuro; Kinya Otsu
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

6.  Calpain inhibition preserves myocardial structure and function following myocardial infarction.

Authors:  Santhosh K Mani; Sundaravadivel Balasubramanian; Juozas A Zavadzkas; Laura B Jeffords; William T Rivers; Michael R Zile; Rupak Mukherjee; Francis G Spinale; Dhandapani Kuppuswamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-04       Impact factor: 4.733

7.  Cross-sex hormonal replacement: is this really effective? an experimental clue.

Authors:  Natalia Pavón; Israel Pérez-Torres; Alberto Aranda; Francisco-Javier Roldán; Cristina Paredes; Edmundo Chávez
Journal:  Endocrine       Date:  2013-02-26       Impact factor: 3.633

8.  Intra-sarcoplasmic reticulum Ca2+ oscillations are driven by dynamic regulation of ryanodine receptor function by luminal Ca2+ in cardiomyocytes.

Authors:  Sarah C W Stevens; Dmitry Terentyev; Anuradha Kalyanasundaram; Muthu Periasamy; Sandor Györke
Journal:  J Physiol       Date:  2009-08-24       Impact factor: 5.182

9.  Cardiomyocyte ryanodine receptor degradation by chaperone-mediated autophagy.

Authors:  Zully Pedrozo; Natalia Torrealba; Carolina Fernández; Damian Gatica; Barbra Toro; Clara Quiroga; Andrea E Rodriguez; Gina Sanchez; Thomas G Gillette; Joseph A Hill; Paulina Donoso; Sergio Lavandero
Journal:  Cardiovasc Res       Date:  2013-02-11       Impact factor: 10.787

10.  Cardioprotective effects of triiodothyronine supplementation against ischemia reperfusion injury by preserving calcium cycling proteins in isolated rat hearts.

Authors:  Lichao Fang; Zhiping Xu; Jian Lu; Lei Hong; Shigang Qiao; Lijun Liu; Jianzhong An
Journal:  Exp Ther Med       Date:  2019-10-21       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.